In what has been referred to as an effort to limit and/or test the U.S. Food and Drug Administration's (FDA) regulatory power, an investigational vaccine for herpes is being tested on the Caribbean island of St. Kitts without FDA or institutional review board approval. Clinical testing on the...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.